What we do

GenomOncology has developed a proprietary technology platform to streamline the use of next generation sequencing data (NGS) in medicine and research.

Everything necessary for a molecular pathology lab to efficiently design, validate and operate an NGS-based Laboratory Developed Test (LDT),
including software, expertise, integration technology and on-site training, is provided by GenomOncology.

LEARN MORE

 

See How It Works

 

Who we are

GenomOncology is focused on enabling precision medicine by translating next generation sequencing data into actionable information for clinicians and researchers.

MEET THE TEAM

 

Why we are different